Gimv — 2013 Investments

1 investments dated 2013 · listed companies and verified rows first · show all

Complixcomplix.comJun 2013

Complix develops therapeutic biologics based on Alphabody technology targeting viral diseases, oncology, and autoimmune conditions.

AI & Machine LearningBiotechDeep TechMedical Devices

Co-investorsPMV Andera Partners Vesalius Biocapital Partners Omnes Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.